In order to further promote the construction and development of tumor immunotherapy, deepen the learning of new knowledge and new progress in head and neck tumor radiotherapy, surgical treatment, immunotherapy, targeted therapy and so on. Chengdu High-tech Medical Association successfully held the second and third sessions of the "Seminar on Surgical Treatment of Head and Neck Cancer" on February 23 and March 5, 2023.

Hosted by Chengdu High-tech Medical Association, the conference invited well-known experts in the field of head and neck cancer surgery in various provinces to give lectures, focusing on topics such as head and neck cancer treatment and adverse reactions caused by chemotherapy, and building a platform for exchange and learning for experts and colleagues in the form of academic lectures and case discussions.

This conference provides a platform for the exchange of diagnosis and treatment technology and academic scientific research achievements for the majority of clinical practitioners and scientific research workers, which is conducive to promoting the academic development of clinical research and medical oncology and related disciplines, and is of great significance for promoting high-quality clinical research and promoting the level of clinical research in the field of medical head and neck cancer surgery.